Congressmembers Langworthy, Schrier Introduce Bipartisan Bill to Lower Prescription Drug Costs by Expanding Access to Biosimilars
glad to introduce this legislation to streamline the FDA’s process, lower drug prices, and make medicine more … bipartisan Expedited Access to Biosimilars Act would streamline the approval process for more affordable alternatives to high-priced